ANI PHARMACEUTICALS, INC Inventory
ANI PHARMACEUTICALS, INC (ANIP) had Inventory of $143.15 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryNet · last filed 2026-08-07
- 2026-06-30: Inventory, Net $143.15M.
- 2026-03-31: Inventory, Net $143.47M.
- 2025-12-31: Inventory, Net $143.07M.
- 2025-09-30: Inventory, Net $146.47M.
| Period end | Inventory, Net | Inventory, Net as first filed |
|---|---|---|
| 2026-06-30 | $143.15M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $143.47M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $143.07M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $146.47M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $138.31M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $137.41M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $136.78M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $148.04M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $125.45M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $113.84M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $111.20M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $106.59M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $104.32M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $103.65M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $105.36M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $95.89M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $92.55M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $83.16M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $81.69M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $61.68M 10-Q · filed 2021-11-01 | |
| 2021-06-30 | $67.63M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $59.93M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $60.80M 10-K · filed 2022-03-15 | |
| 2020-09-30 | $59.20M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $52.56M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $52.90M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $48.16M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $46.17M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $45.30M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $42.03M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $40.50M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $40.01M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $37.76M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $34.29M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $37.73M 10-K · filed 2019-02-27 | |
| 2017-09-30 | $38.48M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $42.31M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $45.89M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $26.18M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $28.26M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $25.05M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $13.92M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $13.39M 10-K · filed 2017-03-02 | |
| 2015-09-30 | $13.74M 10-Q · filed 2015-11-03 | |
| 2015-06-30 | $12.70M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $10.74M 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $7.52M 10-K · filed 2016-02-23 | |
| 2014-09-30 | $7.35M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $5.91M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $5.09M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $3.52M 10-K · filed 2015-02-23 | |
| 2013-09-30 | $2.81M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $2.58M 10-Q · filed 2013-08-09 | |
| 2012-12-31 | $2.81M 10-K · filed 2014-02-28 | $2.81M 10-Q · filed 2013-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |